FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064171176> ?p ?o ?g. }

• W2064171176 endingPage "13724" @default.
• W2064171176 startingPage "13710" @default.
• W2064171176 abstract "A-500359s, A-503083s, and A-102395 are capuramycin-type nucleoside antibiotics that were discovered using a screen to identify inhibitors of bacterial translocase I, an essential enzyme in peptidoglycan cell wall biosynthesis. Like the parent capuramycin, A-500359s and A-503083s consist of three structural components: a uridine-5′-carboxamide (CarU), a rare unsaturated hexuronic acid, and an aminocaprolactam, the last of which is substituted by an unusual arylamine-containing polyamide in A-102395. The biosynthetic gene clusters for A-500359s and A-503083s have been reported, and two genes encoding a putative non-heme Fe(II)-dependent α-ketoglutarate:UMP dioxygenase and an l-Thr:uridine-5′-aldehyde transaldolase were uncovered, suggesting that C–C bond formation during assembly of the high carbon (C6) sugar backbone of CarU proceeds from the precursors UMP and l-Thr to form 5′-C-glycyluridine (C7) as a biosynthetic intermediate. Here, isotopic enrichment studies with the producer of A-503083s were used to indeed establish l-Thr as the direct source of the carboxamide of CarU. With this knowledge, the A-102395 gene cluster was subsequently cloned and characterized. A genetic system in the A-102395-producing strain was developed, permitting the inactivation of several genes, including those encoding the dioxygenase (cpr19) and transaldolase (cpr25), which abolished the production of A-102395, thus confirming their role in biosynthesis. Heterologous production of recombinant Cpr19 and CapK, the transaldolase homolog involved in A-503083 biosynthesis, confirmed their expected function. Finally, a phosphotransferase (Cpr17) conferring self-resistance was functionally characterized. The results provide the opportunity to use comparative genomics along with in vivo and in vitro approaches to probe the biosynthetic mechanism of these intriguing structures.Background: Several nucleoside antibiotics contain a uridine-5′-carboxamide core of unclear origin.Results: The A-102395 biosynthetic gene cluster was cloned, a genetic system was developed, and three enzymes were characterized in vivo and in vitro.Conclusion: Uridine-5′-carboxamide originates from UMP and l-Thr by sequential reactions catalyzed by a dioxygenase and transaldolase.Significance: The results provide the first opportunity to methodically interrogate the biosynthesis of these unusual antibiotics. A-500359s, A-503083s, and A-102395 are capuramycin-type nucleoside antibiotics that were discovered using a screen to identify inhibitors of bacterial translocase I, an essential enzyme in peptidoglycan cell wall biosynthesis. Like the parent capuramycin, A-500359s and A-503083s consist of three structural components: a uridine-5′-carboxamide (CarU), a rare unsaturated hexuronic acid, and an aminocaprolactam, the last of which is substituted by an unusual arylamine-containing polyamide in A-102395. The biosynthetic gene clusters for A-500359s and A-503083s have been reported, and two genes encoding a putative non-heme Fe(II)-dependent α-ketoglutarate:UMP dioxygenase and an l-Thr:uridine-5′-aldehyde transaldolase were uncovered, suggesting that C–C bond formation during assembly of the high carbon (C6) sugar backbone of CarU proceeds from the precursors UMP and l-Thr to form 5′-C-glycyluridine (C7) as a biosynthetic intermediate. Here, isotopic enrichment studies with the producer of A-503083s were used to indeed establish l-Thr as the direct source of the carboxamide of CarU. With this knowledge, the A-102395 gene cluster was subsequently cloned and characterized. A genetic system in the A-102395-producing strain was developed, permitting the inactivation of several genes, including those encoding the dioxygenase (cpr19) and transaldolase (cpr25), which abolished the production of A-102395, thus confirming their role in biosynthesis. Heterologous production of recombinant Cpr19 and CapK, the transaldolase homolog involved in A-503083 biosynthesis, confirmed their expected function. Finally, a phosphotransferase (Cpr17) conferring self-resistance was functionally characterized. The results provide the opportunity to use comparative genomics along with in vivo and in vitro approaches to probe the biosynthetic mechanism of these intriguing structures. Background: Several nucleoside antibiotics contain a uridine-5′-carboxamide core of unclear origin. Results: The A-102395 biosynthetic gene cluster was cloned, a genetic system was developed, and three enzymes were characterized in vivo and in vitro. Conclusion: Uridine-5′-carboxamide originates from UMP and l-Thr by sequential reactions catalyzed by a dioxygenase and transaldolase. Significance: The results provide the first opportunity to methodically interrogate the biosynthesis of these unusual antibiotics." @default.
• W2064171176 created "2016-06-24" @default.
• W2064171176 creator A5003353735 @default.
• W2064171176 creator A5006043426 @default.
• W2064171176 creator A5015049249 @default.
• W2064171176 creator A5021345410 @default.
• W2064171176 creator A5035168940 @default.
• W2064171176 creator A5038929544 @default.
• W2064171176 creator A5040032635 @default.
• W2064171176 creator A5041145272 @default.
• W2064171176 creator A5041721918 @default.
• W2064171176 creator A5052737536 @default.
• W2064171176 creator A5060345204 @default.
• W2064171176 creator A5060684279 @default.
• W2064171176 creator A5070623632 @default.
• W2064171176 creator A5074900954 @default.
• W2064171176 creator A5077557326 @default.
• W2064171176 creator A5087678652 @default.
• W2064171176 date "2015-05-01" @default.
• W2064171176 modified "2023-10-14" @default.
• W2064171176 title "The Biosynthesis of Capuramycin-type Antibiotics" @default.
• W2064171176 cites W1539666465 @default.
• W2064171176 cites W1580813389 @default.
• W2064171176 cites W1608416197 @default.
• W2064171176 cites W1954531392 @default.
• W2064171176 cites W1964160472 @default.
• W2064171176 cites W1967314547 @default.
• W2064171176 cites W1969393758 @default.
• W2064171176 cites W1969863120 @default.
• W2064171176 cites W1970954035 @default.
• W2064171176 cites W1974809824 @default.
• W2064171176 cites W1977926564 @default.
• W2064171176 cites W1979226989 @default.
• W2064171176 cites W1986853290 @default.
• W2064171176 cites W1988594072 @default.
• W2064171176 cites W1988916934 @default.
• W2064171176 cites W1990342103 @default.
• W2064171176 cites W1996910049 @default.
• W2064171176 cites W2000269080 @default.
• W2064171176 cites W2001189466 @default.
• W2064171176 cites W2001351478 @default.
• W2064171176 cites W2006575088 @default.
• W2064171176 cites W2010073642 @default.
• W2064171176 cites W2012945630 @default.
• W2064171176 cites W2017508549 @default.
• W2064171176 cites W2023693474 @default.
• W2064171176 cites W2025760279 @default.
• W2064171176 cites W2029980303 @default.
• W2064171176 cites W2033714675 @default.
• W2064171176 cites W2038316974 @default.
• W2064171176 cites W2039320237 @default.
• W2064171176 cites W2050312203 @default.
• W2064171176 cites W2052603675 @default.
• W2064171176 cites W2057972333 @default.
• W2064171176 cites W2063399270 @default.
• W2064171176 cites W2064587167 @default.
• W2064171176 cites W2066068871 @default.
• W2064171176 cites W2067880899 @default.
• W2064171176 cites W2075163051 @default.
• W2064171176 cites W2076413815 @default.
• W2064171176 cites W2081191597 @default.
• W2064171176 cites W2093907473 @default.
• W2064171176 cites W2095213110 @default.
• W2064171176 cites W2096777666 @default.
• W2064171176 cites W2097118224 @default.
• W2064171176 cites W2103620979 @default.
• W2064171176 cites W2108028807 @default.
• W2064171176 cites W2111386687 @default.
• W2064171176 cites W2113529450 @default.
• W2064171176 cites W2114473080 @default.
• W2064171176 cites W2116806922 @default.
• W2064171176 cites W2120117471 @default.
• W2064171176 cites W2122660082 @default.
• W2064171176 cites W2127258416 @default.
• W2064171176 cites W2128552872 @default.
• W2064171176 cites W2128586767 @default.
• W2064171176 cites W2134652558 @default.
• W2064171176 cites W2138724425 @default.
• W2064171176 cites W2144940672 @default.
• W2064171176 cites W2147680301 @default.
• W2064171176 cites W2147873315 @default.
• W2064171176 cites W2151107150 @default.
• W2064171176 cites W2152660769 @default.
• W2064171176 cites W2154063145 @default.
• W2064171176 cites W2161444872 @default.
• W2064171176 cites W2162624487 @default.
• W2064171176 cites W2166045439 @default.
• W2064171176 cites W2174092892 @default.
• W2064171176 cites W2179183779 @default.
• W2064171176 cites W2181194591 @default.
• W2064171176 cites W2952964820 @default.
• W2064171176 doi "https://doi.org/10.1074/jbc.m115.646414" @default.
• W2064171176 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4447950" @default.
• W2064171176 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25855790" @default.
• W2064171176 hasPublicationYear "2015" @default.
• W2064171176 type Work @default.
• W2064171176 sameAs 2064171176 @default.
• W2064171176 citedByCount "27" @default.

• next